Moska Hellamand is a Researcher for the Access to Medicine Index and the Antimicrobial Resistance Benchmark. She holds a Bachelor’s (honours) degree in Pharmaceutical Sciences and a Master’s degree in Drug Innovation from Utrecht University. During her Masters studies, Moska conducted research on the Essential Medicines List at the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, specifically looking into the selection of Essential Medicines for TB, HIV, oncology and Hepatitis C.
Moska also participated in the Honours Programme of Pharmaceutical Sciences with a focus on research and the Avicenna Excellence Program with a focus on healthcare. She holds the Bright Minds Award from Utrecht University and the Best Healthcare Innovation Award from the Avicenna Excellence Program.